Company profile
MediPharm Labs Corp.
OTC: MEDIF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Barrie, ONReports USD
#492 of 1,418 Healthcare companies by revenue49th-percentile growth
EA Score
61CFH 63DQ —GM 62SS 47
v0.1 · 45/100 weight · provisional
↑ balance-sheet leverage, 3-yr revenue growth · ↓ listing tenure, Piotroski F
Methodology →Revenue TTM
$30.0M
Rev growth YoY (TTM)
-5.8%
Net income (FY)
-$5.9M
Employees
127
as of 2026-08-21
Market cap
$24.2M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$32.3M45.1M CAD2025
Net income-$5.9M-8.3M CAD2025
Operating income-$6.2M-8.6M CAD2025
Total assets$33.3M45.7M CAD2025
Liabilities$7.2M9.9M CAD2025
Equity$26.1M35.8M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is MediPharm Labs Corp.’s revenue?
MediPharm Labs Corp. booked $32.3M in FY2025 revenue, growing 5.3% year over year — about the middle of the pack among Healthcare companies we track, at a -18.3% net margin.
Peers · Healthcare
Grown Rogue International Inc.52DStereotaxis, Inc.55CAoxing Pharmaceutical Company, Inc.——electroCore, Inc.57CNova Leap Health Corp.75B+Sonendo, Inc.——Key facts
CEOGreg Hunter
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersBarrie, ON
ExchangeOTC: MEDIF
Employees127
IPO date2021-01-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.